Startup podcast guide
Global Trial Accelerators™
Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial…
Overview
Global Trial Accelerators™ podcast overview
About Global Trial Accelerators™
Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.What You’ll Learn:Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.Why Listen?Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early.Regulatory Intel: Stay ahead of shifting LATAM, Balkans, and APAC guidelines with on-the-ground experts.Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets.“bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay. This podcast is why we partnered with them.”– Digital Health Startup CEONew episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity.Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.
Why Upseed includes it
The podcast provides insights into clinical trials and regulatory strategies relevant to Medtech and Biopharma startups, featuring startup founders and focusing on emerging markets.
Who may find it useful
Founders, Operators, Investors may find this series useful. Its recurring topics include Medtech, Biotech, Healthtech, Emerging Markets, Startup Building, Regulatory Strategy.
Operational profile
Series profile
These publication facts describe the series record. Recent publishing activity appears under Track record.
- Series type
- Episodic
- Content type
- Audio
- Published by
- Julio G. Martinez-Clark
- Language
- English
- Geographic focus
- Global
- Last reviewed
- March 17, 2026
- Published episodes
- 119
- publisher-supplied series count
- Recent episodes linked
- 12
- admitted official episode destinations
- Series first published
- March 18, 2019
- publisher-supplied publication metadata
- Latest episode
- February 23, 2023
- latest official destination found
Publication metadata and latest official episode destinations · Independent Upseed startup-relevance assessment · March 17, 2026
Latest episodes
Listen at the publisher's destination
Upseed links out to the destinations supplied by the publisher and does not host or reproduce the audio.
.jpg){kind=small}
Common questions
Using this podcast guide
No. Upseed independently researches and organizes startup information. The show description, artwork, and episode destinations originate from the podcast's public distribution metadata.
Source and update disclosure
Know what this page is based on
Source basis
Public podcast distribution metadata, publisher-supplied destinations, and structured Upseed relevance research.
Last reviewed
March 17, 2026
Known limits
Series description, artwork, author, publication count, and episode destinations come from public podcast distribution metadata. Startup relevance, topics, audience, and inclusion are Upseed's machine-assisted assessment. Verify current details at the publisher's official destination.
Upseed is an independent guide. It is not affiliated with Global Trial Accelerators™, its publisher, guests, or distribution platforms.